Cisplatin-based combination chemotherapy in elderly patients with metastatic urothelial cancer.

Authors

null

Aristotelis Bamias

HECOG and University of Athens, Athens, Greece

Aristotelis Bamias , Susanne Krege , Chia-Chi Lin , Noah M. Hahn , Thorsten Ecke , Erin L. Moshier , Guru Sonpavde , James H. Godbold , William K. Oh , Angelos Koutras , Yeong-Shiau Pu , Matt D. Galsky

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancer, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancer

Sub Track

Urothelial Carcinoma

Citation

J Clin Oncol 31, 2013 (suppl 6; abstr 269)

DOI

10.1200/jco.2013.31.6_suppl.269

Abstract #

269

Poster Bd #

F16

Abstract Disclosures

Similar Posters

First Author: Maxime Frelaut

Poster

2019 Genitourinary Cancers Symposium

Long-term outcomes in elderly patients (pts) from IMvigor210: Atezolizumab (atezo) in metastatic urothelial cancer (mUC).

Long-term outcomes in elderly patients (pts) from IMvigor210: Atezolizumab (atezo) in metastatic urothelial cancer (mUC).

First Author: Arjun Vasant Balar

Poster

2015 Gastrointestinal Cancers Symposium

Risks of severe adverse events of docetaxel, cisplatin, and 5-fluorouracil (DCF) combination chemotherapy of esophageal cancer.

Risks of severe adverse events of docetaxel, cisplatin, and 5-fluorouracil (DCF) combination chemotherapy of esophageal cancer.

First Author: Sayako Yuda